|
|
|
Insider
Information: |
Bradsher Neal C |
Relationship: |
10% Owner |
City: |
Union City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
129,185 |
|
Indirect Shares
|
57,363,752 |
|
|
Direct
Value |
$1,132,498 |
|
|
Indirect Value
|
$476,500,084 |
|
|
Total
Shares |
57,492,937 |
|
|
Total
Value |
$477,632,582 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
60
|
50
|
Stock
price went up :
|
44
|
16
|
Stock
price went down : |
16
|
34
|
|
|
|
Gain/Loss Ratio : |
2.8
|
2.8
|
Percentage
Gain/Loss : |
9.9%
|
-929.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Questcor Pharmaceuticals Inc |
QCOR |
Director |
2014-08-14 |
0 |
2014-08-14 |
0 |
Premium* |
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director, 10% Owner |
2024-02-06 |
87,628 |
2024-02-06 |
41,666,255 |
Premium* |
|
Comarco Inc |
CMRO |
10% Owner |
2017-09-15 |
15,500 |
2017-09-15 |
0 |
Premium* |
|
STAAR Surgical Co |
STAA |
10% Owner |
2024-05-09 |
25,900 |
2024-05-09 |
10,768,431 |
Premium* |
|
Palomar Medical Technologies Inc |
PMTI |
10% Owner |
2013-06-24 |
0 |
2013-06-24 |
0 |
Premium* |
|
Asterias Biotherapeutics Inc |
AST |
See Remarks Below |
2019-03-08 |
0 |
2019-03-08 |
0 |
Premium* |
|
Oncocyte Corp |
OCX |
10% Owner |
2024-04-11 |
157 |
2024-04-11 |
4,929,066 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
612 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 24 of 25
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2022-03-25 |
4 |
B |
$1.44 |
$678,022 |
D/D |
470,000 |
34,935,485 |
3.92 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2014-02-25 |
4 |
B |
$3.74 |
$1,870,000 |
D/D |
500,000 |
9,822,262 |
3.92 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2019-02-08 |
4 |
B |
$3.75 |
$1,999,999 |
D/D |
533,333 |
8,098,267 |
2.45 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2017-07-21 |
4 |
OE |
$3.25 |
$1,755,000 |
D/D |
540,000 |
3,596,680 |
0 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2016-02-11 |
4/A |
B |
$6.01 |
$3,329,937 |
D/D |
554,066 |
10,417,670 |
2.45 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2016-02-11 |
4 |
B |
$6.01 |
$3,329,937 |
D/D |
554,066 |
0 |
2.45 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2021-09-23 |
4 |
OE |
$3.15 |
$1,807,836 |
D/D |
573,461 |
17,349,945 |
0 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2021-02-05 |
4 |
B |
$4.50 |
$2,700,000 |
D/D |
600,000 |
16,776,484 |
2.45 |
% |
|
AST |
Asterias Biotherapeutics ... |
See Remarks Section |
|
2015-02-10 |
4 |
A |
$3.90 |
$2,499,998 |
D/D |
641,025 |
641,025 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2014-06-16 |
4 |
B |
$2.50 |
$2,500,000 |
D/D |
1,000,000 |
13,422,262 |
3.92 |
- |
|
AST |
Asterias Biotherapeutics ... |
See Remarks Section |
|
2015-05-21 |
4 |
OE |
$2.34 |
$2,340,000 |
D/D |
1,000,000 |
1,641,025 |
0 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2019-07-02 |
4 |
B |
$2.00 |
$2,000,000 |
D/D |
1,000,000 |
9,098,267 |
2.45 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2020-04-24 |
4 |
B |
$2.27 |
$2,383,500 |
D/D |
1,050,000 |
14,716,204 |
2.45 |
% |
|
LCTX |
Lineage Cell Therapeutics... |
10% Owner |
|
2009-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,100,000 |
2,931,153 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2009-07-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,100,000 |
4,031,153 |
0 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2009-06-16 |
4 |
B |
$1.88 |
$2,179,601 |
D/D |
1,159,362 |
6,028,638 |
2.45 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2020-01-02 |
4 |
B |
$2.16 |
$3,000,001 |
D/D |
1,391,466 |
13,666,204 |
2.45 |
% |
|
LCTX |
Lineage Cell Therapeutics... |
10% Owner |
|
2010-08-13 |
4 |
OE |
$1.82 |
$2,570,094 |
D/D |
1,413,693 |
42,908 |
0 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2021-01-20 |
4 |
B |
$3.42 |
$4,999,999 |
D/D |
1,460,280 |
16,176,484 |
2.45 |
% |
|
CMRO |
Comarco Inc |
10% Owner |
|
2017-09-15 |
4 |
S |
$0.00 |
$1,549 |
D/D |
(1,548,636) |
0 |
0 |
- |
|
AST |
Asterias Biotherapeutics ... |
See Remarks Section |
|
2017-10-16 |
4 |
B |
$2.60 |
$4,140,001 |
D/D |
1,592,308 |
5,292,156 |
2.44 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2015-10-02 |
4 |
A |
$3.19 |
$5,104,000 |
D/D |
1,600,000 |
21,864,396 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2014-08-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,818,248) |
0 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2014-05-01 |
4 |
B |
$2.52 |
$5,040,000 |
D/D |
2,000,000 |
11,822,262 |
3.92 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2019-09-11 |
4 |
B |
$1.66 |
$3,320,000 |
D/D |
2,000,000 |
11,098,267 |
2.45 |
- |
|
612 Records found
|
|
Page 24 of 25 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|